IDEXX Laboratories, Inc. vs Royal Caribbean Cruises Ltd — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while Royal Caribbean Cruises Ltd trades at $286.28 (market cap $76.75B). The key difference: Royal Caribbean Cruises Ltd is the larger of the two by market cap, and Royal Caribbean Cruises Ltd pays a 1.75% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | RCL | |
|---|---|---|
Market Cap | $44.48B | $76.75B |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $365.84 |
52-Week Low | $520.87 | $246.71 |
Enterprise Value | $45.38B | $98.03B |
Dividend Yield | — | 1.75% |
Trailing returns across standard periods
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →